Protara Therapeutics Inc. (TARA) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Protara Therapeutics Inc.

    NASDAQ: TARA · Real-Time Price · USD
    4.96
    0.74 (17.54%)
    At close: Oct 03, 2025, 3:59 PM
    4.97
    0.20%
    After-hours: Oct 03, 2025, 07:56 PM EDT

    Protara Therapeutics Ratios and Metrics

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    PE Ratio
    		 -2.44 -0.53 -0.46 -1.61
    PEG Ratio
    		 0.06 0.01 -0.01 0.15
    PS Ratio
    		 n/a n/a n/a n/a
    PB Ratio
    		 0.65 0.31 0.30 0.47
    P/FCF Ratio
    		 -3.03 -0.57 -1.14 -2.16
    P/OCF Ratio
    		 -3.04 -0.57 -1.14 -2.2
    OCF/S Ratio
    		 n/a n/a n/a n/a
    Debt / Equity Ratio
    		 0.03 0.08 0.06 0.04
    Quick Ratio
    		 15.71 11.17 14.81 21.66
    Current Ratio
    		 15.71 11.17 15.01 21.66
    Asset Turnover
    		 n/a n/a n/a n/a
    Interest Coverage
    		 n/a n/a -58.98 -27.34
    Return on Equity
    		 -0.27 -0.59 -0.65 -0.29
    Return on Assets
    		 -0.25 -0.51 -0.58 -0.27
    Return on Invested Capital
    		 -0.28 -0.59 -0.61 -0.28
    Dividend Yield
    		 n/a n/a n/a n/a
    Payout Ratio
    		 n/a n/a n/a n/a
    Gross Profit Margin
    		 n/a n/a n/a n/a
    Net Profit Margin
    		 n/a n/a n/a n/a
    Pretax Profit Margin
    		 n/a n/a n/a n/a
    Operating Profit Margin
    		 n/a n/a n/a n/a
    FCF Margin
    		 n/a n/a n/a n/a
    EBITDA Margin
    		 n/a n/a n/a n/a

    Add to Watchlist